Agile Therapeutics Cash from Investing (TTM) Analysis

Agile Therapeutics Inc (AGRX)

0.3678 -0.02 (-4.62%) USD | OTCM | Apr 17, 15:44

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	0.00
September 30, 2023	0.00
June 30, 2023	0.00
March 31, 2023	-0.007M
December 31, 2022	-0.133M
September 30, 2022	-0.188M
June 30, 2022	4.747M
March 31, 2022	23.15M
December 31, 2021	39.46M
September 30, 2021	46.87M
June 30, 2021	41.93M
March 31, 2021	-24.34M
December 31, 2020	-40.69M
September 30, 2020	-48.11M
June 30, 2020	-48.14M
March 31, 2020	-0.262M
December 31, 2019	-0.098M
September 30, 2019	-0.03M
June 30, 2019	-0.002M
March 31, 2019	-0.042M
December 31, 2018	-0.318M

Date	Value
September 30, 2018	-0.86M
June 30, 2018	-1.179M
March 31, 2018	-1.584M
December 31, 2017	-1.313M
September 30, 2017	-0.777M
June 30, 2017	-0.461M
March 31, 2017	-0.034M
December 31, 2016	-0.031M
September 30, 2016	-0.027M
June 30, 2016	-0.035M
March 31, 2016	-0.103M
December 31, 2015	-0.29M
September 30, 2015	-0.3417M
June 30, 2015	-0.3643M
March 31, 2015	-0.2839M
December 31, 2014	-0.096M
September 30, 2014	-0.0951M
June 30, 2014	-0.3182M
March 31, 2014	-1.906M
December 31, 2013	-4.945M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-48.14M

Minimum

Jun 2020

46.87M

Maximum

Sep 2021

-0.3077M

Average

-0.007M

Median

Mar 2023

Cash from Investing (TTM) Benchmarks